The Administrative Core of the PO1, """"""""Structure-function analysis of infection- and vaccine-induced B-cell repertoires"""""""", will be led by the PO1 Principal Investigator, Stephen C. Harnson, working closely with an experienced administrative assistant (to be named), with the grants and financial offices at Children's Hospital, and with IT support provided by SBGnd at Harvard Medical School. The core office will be located adjacent to the Pi's research laboratory. The core will provide organizational structure for the P01; coordinate administrative and financial management;ensure regular communication between staff at Children's Hospital Boston and administrative staff at the collaborating institutions;maintain a PO1 web site, both for external and internal communication;manage communication among PO1 investigators, the external advisory board, and the NIH program officer;coordinate decision making by the PO1 leadership team about scientific priorities and specific collaborative directions;monitor abstract and publication submission for compliance with agreements among the participating organizations;resolve authorship and related conflicts that cannot be settled by the authors or individual Pis; coordinate prompt handling of any IP disclosures that must pass through the technology transfer office at CHB;and coordinate with Pis of the Clinical Core and Projects 1-3, to ensure regulatory compliance and quality control for protection of human subjects as well as compliance with regulations in all other areas (e.g., animal use, radiation, biosafety).

Public Health Relevance

The work will have a significant impact on influenza vaccine development and for immunization against other pathogens with rapid antigenic variation. The project will also lead to a greatly improved understanding of the human immune response to vaccines and to the implementation of novel structural methods in virology and immunology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI089618-04
Application #
8720680
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Finney, Joel; Yeh, Chen-Hao; Kelsoe, Garnett et al. (2018) Germinal center responses to complex antigens. Immunol Rev 284:42-50
McCarthy, Kevin R; Watanabe, Akiko; Kuraoka, Masayuki et al. (2018) Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires. Immunity 48:174-184.e9
Raymond, Donald D; Bajic, Goran; Ferdman, Jack et al. (2018) Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody. Proc Natl Acad Sci U S A 115:168-173
Ferdman, Jack; Palladino, Giuseppe; Liao, Hua-Xin et al. (2018) Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine. Vaccine 36:5325-5332
Finney, Joel; Kelsoe, Garnett (2018) Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design. Retrovirology 15:53
Liu, Yuhang; Pan, Junhua; Jenni, Simon et al. (2017) CryoEM Structure of an Influenza Virus Receptor-Binding Site Antibody-Antigen Interface. J Mol Biol 429:1829-1839
Liu, Yuhang; Pan, Junhua; Cai, Yongfei et al. (2017) Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer. J Virol 91:
Kuraoka, Masayuki; Schmidt, Aaron G; Nojima, Takuya et al. (2016) Complex Antigens Drive Permissive Clonal Selection in Germinal Centers. Immunity 44:542-552
Raymond, Donald D; Stewart, Shaun M; Lee, Jiwon et al. (2016) Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain. Nat Med 22:1465-1469
Lee, Jiwon; Boutz, Daniel R; Chromikova, Veronika et al. (2016) Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat Med 22:1456-1464

Showing the most recent 10 out of 18 publications